Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Low-quality compounds may contain residual synthesis impurities, degraded fragments, oxidized material, or inconsistent concentrations all of which interfere with receptor signaling studies, reproducibility, and dose-response analysis
In January, the National Association of Medicaid Directors told the federal Centers for Medicare & Medicaid Services that state Medicaid departments had significant concerns over the fiscal impacts of the Biden proposal to require coverage of GLP-1s, and strongly recommend that CMS maintain the current state option to cover or not cover anti-obesity medications. But others say covering the drugs will yield long-term savings
doi: 10.1016/j.phymed.2021.153712 5
However, it should be emphasized that use of caloric restriction to control for weight-dependent effects in DIO mouse studies may potentially introduce confounding effects on microbiome signatures due to significant compensatory changes in hunger sensation, feeding pattern, resting metabolic rate and gut morphology which may be disproportionately to that attained by appetite suppressants 80,81
No evidence of significant cortisol elevation, prolactin disturbance, or hepatic adverse effects has been observed in available research data
Today, AOD-9604 remains a topic of scientific interest, not as an approved therapy, but as a case study in how translational challenges can derail promising preclinical results
